Lupin’s New Drug Launch Sends Shares Soaring! Find Out What’s Behind the Surge

Mumbai-based pharmaceutical giant Lupin Limited is making waves in the stock market after launching Rivaroxaban Tablets USP, 2.5 mg, in the United States. The announcement led to a nearly 3% rise in the company’s share price, reflecting strong investor confidence. Rivaroxaban, the generic version of Xarelto® by Janssen Pharmaceuticals, is an anticoagulant designed to prevent … Read more